Market Place
Sourcing Support
Teen Scientists Win $9M+ at 2025 Regeneron ISEF
16 May 2025 //
GLOBENEWSWIRE
Sanofi off to a promising start in launch of Dupixent for COPD
24 Apr 2025 //
FIERCE PHARMA
DiMe, Big Pharmas collab on framework for digital endpoints
12 Jun 2024 //
FIERCE BIOTECH
Rezolute’s oral Eylea rival hits phase 2 goal, sending stock up
22 May 2024 //
FIERCE BIOTECH
Big Pharma ad spending edges toward $7B with Big Pharmas leading the way
23 Mar 2022 //
ENDPTS
Eli Lilly, Regeneron antibody therapies lose out against Omicron
15 Dec 2021 //
REUTERS
Factbox: Front runners in development of antibody drugs against COVID-19
17 Nov 2021 //
REUTERS
Panel finds efficacy for Regeneron’s REGEN-COV in Phase III Covid-19 trial
25 Feb 2021 //
PHARMACEUTICAL-TECHNOLOGY
Coronavirus-hit Czechs order Regeneron antibody drug ahead of EU registration
22 Feb 2021 //
REUTERS
New Dupixent® (dupilumab) Data Showcasing Improvements Four Type 2 Inflammatory
01 Feb 2021 //
PRNEWSWIRE
Regeneron scores $2.6B US supply deal for antibody cocktail
13 Jan 2021 //
ENDPTS
Exclusive-Dialysis clinics provide new path for delivery of stockpiled COVID-19
30 Dec 2020 //
YAHOO
Regeneron teams with gene therapy pioneer James Wilson, adapting its Covid-19
30 Nov 2020 //
ENDPTS
In a second big setback for Covid-19 antibody treatment hopes, Regeneron halts
30 Oct 2020 //
ENDPTS
Regeneron Covid-19 Therapy Reduces Viral Load, Need for Care
29 Oct 2020 //
BLOOMBERG
Fauci, Collins intervene to stop FDA plasma authorization, citing weak data
19 Aug 2020 //
ENDPTS
Pharma`s TV ad spending level sets in June
16 Jul 2020 //
FIERCEPHARMA
OWS shifts spotlight to drugs to fight Covid-19, handing Regeneron $450M
07 Jul 2020 //
ENDPTS
New Publication Highlights Preclinical Research Showing Potential Libtayo®
24 Jun 2020 //
PRNEWSWIRE
Federal prosecutors allege Regeneron used a charity to pay kickbacks
24 Jun 2020 //
STATNEWS
Two Science Publications Highlight Potential of REGN-COV2 Anti-Viral Antibody
10 Jun 2020 //
PRNEWSWIRE
A closer look at the race to develop antibody drugs for COVID-19
12 May 2020 //
BIOPHARMADIVE
Battling low expectations and goliath rivals, Regeneron/Sanofi add +ve Libtayo
04 May 2020 //
ENDPTS
Inside Regeneron, shared urgency drives COVID-19 efforts
20 Mar 2020 //
FIERCEP HARMA
Dupixent cleared for chronic rhinosinusitis in EU; FDA grants RMAT
29 Oct 2019 //
ENDPTS
Ebola trial stopped early as Regeneron, Ridgeback therapies cut death risk
12 Aug 2019 //
ENDPTS
Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
12 Feb 2019 //
REUTERS
Sanofi, Regeneron offer Praluent® (alirocumab) at new reduced U.S. list price
11 Feb 2019 //
PR NEWSWIRE
GSK looks to oncology for growth as Advair generic hits
06 Feb 2019 //
FIERCE PHARMA
Decibel hires new CMO ahead of proof-of-concept hearing loss studies
05 Feb 2019 //
FIERCE BIOTECH
Sanofi agrees to pay Regeneron $462M for an early wrap of their big I/O alliance
08 Jan 2019 //
ENDPTS
Bispecifics vs CAR-T: Analysts select the big winners — and losers
05 Dec 2018 //
ENDPTS
ICER finds top asthma biologics overpriced
26 Sep 2018 //
BIOPHARMA DIVE
Positive Ph 3 Results Presented for Dupixent® (dupilumab) in Atopic Dermatitis
15 Sep 2018 //
PR NEWSWIRE
What You May Have Missed: Top Biotech Stories for the Month of August
03 Sep 2018 //
BIOSPACE
TCR deal frenzy continues as bluebird antes up $30M for new Gritstone alliance
23 Aug 2018 //
ENDPTS
US Rheumatologists` Early Views on Eli Lilly`s Olumiant for RA
20 Aug 2018 //
PR NEWSWIRE
An eye drop for macular degeneration shows promise in animal studies
20 Jul 2018 //
FIERCE BIOTECH
5 Top Biotech Stocks That Look Vulnerable in 2018
09 Jan 2018 //
BIOSACE
Synthetic peptide outlasts macular degeneration med Eyelea in animal models
18 Jan 2017 //
FIERCE BIOTECH
